Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 3
2012 3
2013 1
2015 5
2016 1
2017 2
2019 5
2020 5
2021 5
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Anti-AGO1 Antibodies Identify a Subset of Autoimmune Sensory Neuronopathy.
Moritz CP, Tholance Y, Vallayer PB, Do LD, Muñiz-Castrillo S, Rogemond V, Ferraud K, La Marca C, Honnorat J, Killian M, Paul S, Camdessanché JP, Antoine JG. Moritz CP, et al. Among authors: tholance y. Neurol Neuroimmunol Neuroinflamm. 2023 Apr 18;10(3):e200105. doi: 10.1212/NXI.0000000000200105. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37072227 Free PMC article.
Unclear association between COVID-19 and Guillain-Barré syndrome.
Vogrig A, Moritz CP, Camdessanché JP, Tholance Y, Antoine JC, Honnorat J, Gigli GL. Vogrig A, et al. Among authors: tholance y. Brain. 2021 Jun 22;144(5):e45. doi: 10.1093/brain/awab068. Brain. 2021. PMID: 33755098 Free PMC article. No abstract available.
COVID-19 and Guillain-Barré syndrome: Response.
Camdessanché JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. Camdessanché JP, et al. Among authors: tholance y. Rev Neurol (Paris). 2020 Sep;176(7):636-637. doi: 10.1016/j.neurol.2020.05.003. Epub 2020 May 15. Rev Neurol (Paris). 2020. PMID: 32419708 Free PMC article. No abstract available.
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases.
Do LD, Moritz CP, Muñiz-Castrillo S, Pinto AL, Tholance Y, Brugiere S, Couté Y, Stoevesandt O, Taussig MJ, Rogemond V, Vogrig A, Joubert B, Ferraud K, Camdessanché JP, Antoine JC, Honnorat J. Do LD, et al. Among authors: tholance y. Neurol Neuroimmunol Neuroinflamm. 2021 Jul 28;8(5):e1032. doi: 10.1212/NXI.0000000000001032. Print 2021 Sep. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34321331 Free PMC article.
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.
Levraut M, Laurent-Chabalier S, Ayrignac X, Bigaut K, Rival M, Squalli S, Zéphir H, Alberto T, Pekar JD, Ciron J, Biotti D, Puissant-Lubrano B, Camdessanché JP, Tholance Y, Casez O, Toussaint B, Marion J, Moreau T, Lakomy D, Thomasset A, Maillart E, Sterlin D, Maurousset A, Rocher A, Laplaud DA, Bigot-Corbel E, Bertho PO, Pelletier J, Boucraut J, Labauge P, Vincent T, De Sèze J, Jahn I, Seitz-Polski B, Thouvenot E, Lebrun-Frenay C; Société Francophone de la Sclérose En Plaques (SFSEP). Levraut M, et al. Among authors: tholance y. Neurol Neuroimmunol Neuroinflamm. 2022 Nov 14;10(1):e200049. doi: 10.1212/NXI.0000000000200049. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36376096 Free PMC article.
Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies.
Tholance Y, Moritz CP, Rosier C, Ferraud K, Lassablière F, Reynaud-Federspiel E, França MC Jr, Martinez ARM, Camdessanché JP, Antoine JC; anti-FGFR3 antibody Study Group. Tholance Y, et al. J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):49-57. doi: 10.1136/jnnp-2019-321849. Epub 2019 Nov 5. J Neurol Neurosurg Psychiatry. 2020. PMID: 31690697
33 results